File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity

TitleLow-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity
Authors
Issue Date2017
Citation
Annals of Hematology, 2017, v. 96, p. 647-651 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/244897
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChan, SYT-
dc.contributor.authorLuk, TH-
dc.contributor.authorLau, JS-
dc.contributor.authorKhong, PL-
dc.contributor.authorKwong, YL-
dc.date.accessioned2017-09-18T02:01:02Z-
dc.date.available2017-09-18T02:01:02Z-
dc.date.issued2017-
dc.identifier.citationAnnals of Hematology, 2017, v. 96, p. 647-651-
dc.identifier.urihttp://hdl.handle.net/10722/244897-
dc.languageeng-
dc.relation.ispartofAnnals of Hematology-
dc.titleLow-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity-
dc.typeArticle-
dc.identifier.emailChan, SYT: drtchan@hku.hk-
dc.identifier.emailKhong, PL: plkhong@hku.hk-
dc.identifier.emailKwong, YL: ylkwong@hkucc.hku.hk-
dc.identifier.authorityKhong, PL=rp00467-
dc.identifier.authorityKwong, YL=rp00358-
dc.identifier.doi10.1007/s00277-017-2931-z-
dc.identifier.hkuros278638-
dc.identifier.volume96-
dc.identifier.spage647-
dc.identifier.epage651-
dc.identifier.isiWOS:000396032700014-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats